Combined Gastrointestinal Decontamination in Acute Severe Poisoning

Recruiting Phase 2 Interventional Study
Severe Poisoning With Cardiotropic or Psychotropic Drug Admission to Intensive Care
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Prior Safety Data This treatment has already been tested in at least one earlier human trial.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Trial phase
Phase 2
Study type
Interventional
Purpose
Treatment
Participants needed
200 (estimated)
Sponsor
Assistance Publique - Hôpitaux de Paris · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Gastrointestinal absorption of high dose medication (toxicant) ingested under solid form for suicidal purposes, is prolonged in patients who need intensive care admission and mechanical ventilation. This is due to the large ingested amounts, slowed blood circulation in the digestive system due to low blood pressure, and the formation of conglomerates of pills (pharmacobezoars). We make the hypoth…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: Patient aged ≥18, intoxicated and hospitalised in intensive care AND * Main drug toxicant of functional type (any psychotropic or cardiotropic), adsorbable by activated charcoal And * Main toxicant identified by the history taken by a healthcare professional on the ward or duri…
Contacts

Voicu Sebastian, MD

0149958442

sebastian.voicu@aphp.fr

CONTACT

Megarbane Bruno, Professor

0149958442

bruno.megarbane@aphp.fr

CONTACT